These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 23653274

  • 21. A review of the clinical efficacy of linaclotide in irritable bowel syndrome with constipation.
    Johnston JM, Shiff SJ, Quigley EM.
    Curr Med Res Opin; 2013 Feb; 29(2):149-60. PubMed ID: 23198977
    [Abstract] [Full Text] [Related]

  • 22. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ, Kunkel D, Low K, Conklin JL, Pimentel M.
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [Abstract] [Full Text] [Related]

  • 23. A randomised controlled trial assessing the efficacy and safety of repeated tegaserod therapy in women with irritable bowel syndrome with constipation.
    Tack J, Müller-Lissner S, Bytzer P, Corinaldesi R, Chang L, Viegas A, Schnekenbuehl S, Dunger-Baldauf C, Rueegg P.
    Gut; 2005 Dec; 54(12):1707-13. PubMed ID: 16020489
    [Abstract] [Full Text] [Related]

  • 24. Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints.
    Quigley EM, Tack J, Chey WD, Rao SS, Fortea J, Falques M, Diaz C, Shiff SJ, Currie MG, Johnston JM.
    Aliment Pharmacol Ther; 2013 Jan; 37(1):49-61. PubMed ID: 23116208
    [Abstract] [Full Text] [Related]

  • 25. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
    Wouters MM, Balemans D, Van Wanrooy S, Dooley J, Cibert-Goton V, Alpizar YA, Valdez-Morales EE, Nasser Y, Van Veldhoven PP, Vanbrabant W, Van der Merwe S, Mols R, Ghesquière B, Cirillo C, Kortekaas I, Carmeliet P, Peetermans WE, Vermeire S, Rutgeerts P, Augustijns P, Hellings PW, Belmans A, Vanner S, Bulmer DC, Talavera K, Vanden Berghe P, Liston A, Boeckxstaens GE.
    Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
    [Abstract] [Full Text] [Related]

  • 26. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome.
    Camilleri M, Vazquez-Roque M, Iturrino J, Boldingh A, Burton D, McKinzie S, Wong BS, Rao AS, Kenny E, Månsson M, Zinsmeister AR.
    Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769
    [Abstract] [Full Text] [Related]

  • 27. Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study.
    Song GH, Leng PH, Gwee KA, Moochhala SM, Ho KY.
    Gut; 2005 Oct; 54(10):1402-7. PubMed ID: 15914575
    [Abstract] [Full Text] [Related]

  • 28. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A, Chojnacki J, Wiśiewska-Jarosińska M, Stec-Michalska K, Szadkowski K, Smigielski J, Chojnacki C.
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [Abstract] [Full Text] [Related]

  • 29. Efficacy of Linaclotide in Reducing Abdominal Symptoms of Bloating, Discomfort, and Pain: A Phase 3B Trial Using a Novel Abdominal Scoring System.
    Chang L, Lacy BE, Moshiree B, Kassebaum A, Abel JL, Hanlon J, Bartolini W, Boinpally R, Bochenek W, Fox SM, Mallick M, Tripp K, Omniewski N, Shea E, Borgstein N.
    Am J Gastroenterol; 2021 Sep 01; 116(9):1929-1937. PubMed ID: 34465695
    [Abstract] [Full Text] [Related]

  • 30. Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome.
    Leventer SM, Raudibaugh K, Frissora CL, Kassem N, Keogh JC, Phillips J, Mangel AW.
    Aliment Pharmacol Ther; 2008 Jan 15; 27(2):197-206. PubMed ID: 17973974
    [Abstract] [Full Text] [Related]

  • 31. Rome III functional constipation and irritable bowel syndrome with constipation are similar disorders within a spectrum of sensitization, regulated by serotonin.
    Shekhar C, Monaghan PJ, Morris J, Issa B, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2013 Oct 15; 145(4):749-57; quiz e13-4. PubMed ID: 23872499
    [Abstract] [Full Text] [Related]

  • 32. A preliminary study of melatonin in irritable bowel syndrome.
    Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P.
    J Clin Gastroenterol; 2007 Jan 15; 41(1):29-32. PubMed ID: 17198061
    [Abstract] [Full Text] [Related]

  • 33. Psychometric Analysis of the Abdominal Score From the Diary for Irritable Bowel Syndrome Symptoms-Constipation Using Phase IIb Clinical Trial Data.
    Coon CD, Hanlon J, Abel JL, Lundy JJ, Carson RT, Reasner DS.
    Value Health; 2020 Mar 15; 23(3):362-369. PubMed ID: 32197732
    [Abstract] [Full Text] [Related]

  • 34. Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.
    Ludidi S, Jonkers DM, Koning CJ, Kruimel JW, Mulder L, van der Vaart IB, Conchillo JM, Masclee AA.
    Neurogastroenterol Motil; 2014 May 15; 26(5):705-14. PubMed ID: 24588932
    [Abstract] [Full Text] [Related]

  • 35. Comparison and Assessment of Flixweed and Fig Effects on Irritable Bowel Syndrome with Predominant Constipation: A Single-Blind Randomized Clinical Trial.
    Pourmasoumi M, Ghiasvand R, Darvishi L, Hadi A, Bahreini N, Keshavarzpour Z.
    Explore (NY); 2019 May 15; 15(3):198-205. PubMed ID: 30318190
    [Abstract] [Full Text] [Related]

  • 36. Melatonin improves bowel symptoms in female patients with irritable bowel syndrome: a double-blind placebo-controlled study.
    Lu WZ, Gwee KA, Moochhalla S, Ho KY.
    Aliment Pharmacol Ther; 2005 Nov 15; 22(10):927-34. PubMed ID: 16268966
    [Abstract] [Full Text] [Related]

  • 37. A retrospective and prospective 12-month observational study of the socioeconomic burden of moderate to severe irritable bowel syndrome with constipation in Spain.
    Mearin F, Caballero AM, Serra J, Brotons C, Tantiñà A, Fort E, Martínez-Cerezo FJ, Perelló A, Sánchez-Antolín G, Rey E, Angós Musgo R, Berdier R, Gómez-Rodríguez B, Clavé P, García-Alonso M, Torán-Monserrat P, Tack J.
    Gastroenterol Hepatol; 2019 Mar 15; 42(3):141-149. PubMed ID: 30612850
    [Abstract] [Full Text] [Related]

  • 38. Clinical trial: renzapride treatment of women with irritable bowel syndrome and constipation - a double-blind, randomized, placebo-controlled, study.
    Lembo AJ, Cremonini F, Meyers N, Hickling R.
    Aliment Pharmacol Ther; 2010 May 15; 31(9):979-90. PubMed ID: 20163375
    [Abstract] [Full Text] [Related]

  • 39. Factors Associated With Response to Placebo in Patients With Irritable Bowel Syndrome and Constipation.
    Ballou S, Beath A, Kaptchuk TJ, Hirsch W, Sommers T, Nee J, Iturrino J, Rangan V, Singh P, Jones M, Lembo A.
    Clin Gastroenterol Hepatol; 2018 Nov 15; 16(11):1738-1744.e1. PubMed ID: 29654913
    [Abstract] [Full Text] [Related]

  • 40. Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.
    Houghton LA, Lea R, Agrawal A, Reilly B, Whorwell PJ.
    Gastroenterology; 2006 Oct 15; 131(4):1003-10. PubMed ID: 17030170
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.